FADS2 and metabolic dysfunction-associated steatotic liver disease: The results indicated that by modifying DNA methylation, FADS2 mutation participates in the development of NAFLD.175 By analysing liver biopsies from 47 patients with NAFLD and 18 control participants, the authors found significantly lower global DNA methylation levels in the liver of patients with NAFLD.